Arcutis Biotherapeutics, Inc.
ARQT
Ранг среди акций
#4032
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to... Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
Цена акции
$31.91
Последняя синхронизация: 2026-10-21
Рыночная капитализация
$4.01B
Изменение (1 день)
-2.77%
Изменение (1 год)
61.08%
Страна
US
Торговля Arcutis Biotherapeutics, Inc. (ARQT)
Категория
Healthcare
История цены акций Arcutis Biotherapeutics, Inc. (ARQT)
Наивысшая цена закрытия: $27.20 2026-10-01
Наименьшая цена закрытия: $21.80 2020-01-01
Наименьшая цена закрытия: $21.80 2020-01-01
История цены акций Arcutis Biotherapeutics, Inc. с 2020 по 2026
Годовая динамика цены акций
| Год | Результативность |
|---|---|
| 2026 (TTM) | -13.06% |
| 2025 | 117.39% |
| 2024 | 438.98% |
| 2023 | -84.13% |
| 2022 | -9.27% |
| 2021 | -38.74% |
| 2020 | 0.00% |
Цена акций похожих компаний или конкурентов
| Компания | Цена акций | Изменение 1г% | Страна |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
